Integrated Biopharma, Inc.
INBP
$0.31
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 808.00K | 1.25M | 928.00K | 430.00K | 112.00K |
| Total Depreciation and Amortization | 1.27M | 1.26M | 1.26M | 1.24M | 1.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.49M | 775.00K | 659.00K | 525.00K | 354.00K |
| Change in Net Operating Assets | -1.50M | -2.00M | -531.00K | -1.91M | -744.00K |
| Cash from Operations | 2.07M | 1.29M | 2.32M | 287.00K | 943.00K |
| Capital Expenditure | -191.00K | -347.00K | -576.00K | -571.00K | -553.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.00K | -- | -- | -- | -- |
| Cash from Investing | -205.00K | -347.00K | -576.00K | -571.00K | -553.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.00K | -18.00K | -28.00K | -39.00K | -42.00K |
| Issuance of Common Stock | 86.00K | 18.00K | 18.00K | 0.00 | 13.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 78.00K | 0.00 | -10.00K | -39.00K | -29.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.94M | 941.00K | 1.73M | -323.00K | 361.00K |